339 related articles for article (PubMed ID: 17142323)
1. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
Ryu H; Lee J; Hagerty SW; Soh BY; McAlpin SE; Cormier KA; Smith KM; Ferrante RJ
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19176-81. PubMed ID: 17142323
[TBL] [Abstract][Full Text] [Related]
2. Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.
Lee J; Hagerty S; Cormier KA; Kim J; Kung AL; Ferrante RJ; Ryu H
Hum Mol Genet; 2008 Jun; 17(12):1774-82. PubMed ID: 18319327
[TBL] [Abstract][Full Text] [Related]
3. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.
Wang H; An W; Cao R; Xia L; Erdjument-Bromage H; Chatton B; Tempst P; Roeder RG; Zhang Y
Mol Cell; 2003 Aug; 12(2):475-87. PubMed ID: 14536086
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease.
Ferrante RJ; Ryu H; Kubilus JK; D'Mello S; Sugars KL; Lee J; Lu P; Smith K; Browne S; Beal MF; Kristal BS; Stavrovskaya IG; Hewett S; Rubinsztein DC; Langley B; Ratan RR
J Neurosci; 2004 Nov; 24(46):10335-42. PubMed ID: 15548647
[TBL] [Abstract][Full Text] [Related]
5. Histone H3-K9 methyltransferase ESET is essential for early development.
Dodge JE; Kang YK; Beppu H; Lei H; Li E
Mol Cell Biol; 2004 Mar; 24(6):2478-86. PubMed ID: 14993285
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease.
Lee J; Hwang YJ; Kim Y; Lee MY; Hyeon SJ; Lee S; Kim DH; Jang SJ; Im H; Min SJ; Choo H; Pae AN; Kim DJ; Cho KS; Kowall NW; Ryu H
Acta Neuropathol; 2017 Nov; 134(5):729-748. PubMed ID: 28593442
[TBL] [Abstract][Full Text] [Related]
7. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor.
Yang L; Xia L; Wu DY; Wang H; Chansky HA; Schubach WH; Hickstein DD; Zhang Y
Oncogene; 2002 Jan; 21(1):148-52. PubMed ID: 11791185
[TBL] [Abstract][Full Text] [Related]
9. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.
Schultz DC; Ayyanathan K; Negorev D; Maul GG; Rauscher FJ
Genes Dev; 2002 Apr; 16(8):919-32. PubMed ID: 11959841
[TBL] [Abstract][Full Text] [Related]
10. Modulation of nucleosome dynamics in Huntington's disease.
Stack EC; Del Signore SJ; Luthi-Carter R; Soh BY; Goldstein DR; Matson S; Goodrich S; Markey AL; Cormier K; Hagerty SW; Smith K; Ryu H; Ferrante RJ
Hum Mol Genet; 2007 May; 16(10):1164-75. PubMed ID: 17403718
[TBL] [Abstract][Full Text] [Related]
11. Genomic structure and expression of the mouse ESET gene encoding an ERG-associated histone methyltransferase with a SET domain.
Blackburn ML; Chansky HA; Zielinska-Kwiatkowska A; Matsui Y; Yang L
Biochim Biophys Acta; 2003 Oct; 1629(1-3):8-14. PubMed ID: 14522075
[TBL] [Abstract][Full Text] [Related]
12. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9.
Shirato H; Ogawa S; Nakajima K; Inagawa M; Kojima M; Tachibana M; Shinkai Y; Takeuchi T
J Biol Chem; 2009 Jan; 284(2):733-9. PubMed ID: 19010785
[TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells.
Li H; Rauch T; Chen ZX; Szabó PE; Riggs AD; Pfeifer GP
J Biol Chem; 2006 Jul; 281(28):19489-500. PubMed ID: 16682412
[TBL] [Abstract][Full Text] [Related]
14. Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.
Jiang Y; Matevossian A; Guo Y; Akbarian S
Neuropharmacology; 2011 Jun; 60(7-8):1088-97. PubMed ID: 20869373
[TBL] [Abstract][Full Text] [Related]
15. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.
Matsui T; Leung D; Miyashita H; Maksakova IA; Miyachi H; Kimura H; Tachibana M; Lorincz MC; Shinkai Y
Nature; 2010 Apr; 464(7290):927-31. PubMed ID: 20164836
[TBL] [Abstract][Full Text] [Related]
16. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B.
Yang L; Mei Q; Zielinska-Kwiatkowska A; Matsui Y; Blackburn ML; Benedetti D; Krumm AA; Taborsky GJ; Chansky HA
Biochem J; 2003 Feb; 369(Pt 3):651-7. PubMed ID: 12398767
[TBL] [Abstract][Full Text] [Related]
17. Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.
Guiretti D; Sempere A; Lopez-Atalaya JP; Ferrer-Montiel A; Barco A; Valor LM
Neurobiol Dis; 2016 May; 89():190-201. PubMed ID: 26851501
[TBL] [Abstract][Full Text] [Related]
18. Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B.
Jiang Y; Jakovcevski M; Bharadwaj R; Connor C; Schroeder FA; Lin CL; Straubhaar J; Martin G; Akbarian S
J Neurosci; 2010 May; 30(21):7152-67. PubMed ID: 20505083
[TBL] [Abstract][Full Text] [Related]
19. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly.
Sarraf SA; Stancheva I
Mol Cell; 2004 Aug; 15(4):595-605. PubMed ID: 15327775
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
Ferrante RJ; Kubilus JK; Lee J; Ryu H; Beesen A; Zucker B; Smith K; Kowall NW; Ratan RR; Luthi-Carter R; Hersch SM
J Neurosci; 2003 Oct; 23(28):9418-27. PubMed ID: 14561870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
